Ignite Creation Date:
2025-12-24 @ 1:05 PM
Ignite Modification Date:
2026-03-28 @ 6:31 AM
Study NCT ID:
NCT06632561
Status:
COMPLETED
Last Update Posted:
2024-10-09
First Post:
2024-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Benefits of Empagliflozin in Patients With Heart Failure and Reduced Ejection Fraction Without Diabetes Mellitus
Sponsor:
Ashraf Wasfy Beshay Aziz
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FMBSUREC/06072021/Aziz
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None